Castro Tejera V, Ohman L, Aabakken L, Fellstrom B, et al. Randomised clinical trial and meta-analysis: mesalazine treatment in irritable bowel syndrome-Effects on gastrointestinal symptoms and rectal biomarkers of immune activity. Aliment Pharmacol Ther 2022 Aug 8. doi: 10.1111/apt.17182.
PMID: 35942522